Advertisement for orthosearch.org.uk
Results 1 - 1 of 1
Results per page:
Applied filters
Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 85-B, Issue SUPP_III | Pages 194 - 194
1 Mar 2003
Sankar KR Williamson J Heaton P Wills A Jones D
Full Access

Introduction: Complications of homologous blood transfusion include transmission of infection and development of antibodies. Autologous pre-donation, acute normo-volaemic haemodilution and cell salvage have been used to reduce the use of homologous transfusions.

Surgery for spinal deformities often requires blood transfusion. In February 1999, we started an autologous pre-donation programme for children undergoing spinal deformity surgery.

Methods and results: The case records of the first 15 patients who took part in the programme have been scrutinised and data about pre-donation, haemoglobin, pre- and post-operative hameoglobin, blood loss, blood transfusions, use of blood products, and complications related to pre-donation of blood were obtained and analysed. Similar data from case records of 15 patients, who had surgery for spinal deformities before start of the programme, were used as control.

In the autologous pre-donation group, four received homologous transfusion and 11 escaped exposure to homologous blood or blood products. In comparison in control group 14 out of 15 received homologous transfusion. There was no significant difference between the two groups in terms of diagnosis, operating time, postoperative haemoglobin, body weight and age. Mean operative blood loss in autologous group was less (1190 mls) than in that of the control group (1529 mls).

Of the four patients who received homologous transfusion, two were transfused outside the hospital protocol.

Complications from pre-donation of blood occurred in three patients and were minor. They included minor bruising in two and difficult and painful venous cannulation in one.

Conclusion: In our practice autologous pre-donation resulted in avoidance of homologous blood transfusion in three quarters of patients undergoing spinal deformity surgery. By adopting strategies such as acute normo-volaemic haemodilution, cell salvage and strictly adhering to protocols for prescribing transfusion, we believe that the need for homologous transfusion could be obviated except in extreme cases.